IRS Issues Proposed Rule on Medicare Drug Negotiation Excise Tax Reporting
- September 29, 2023
The Internal Revenue Service (IRS) issued a notice of proposed rulemaking that provides guidance on reporting liability for the excise tax that may be imposed on manufacturers, producers, or importers of designated drugs that fail to negotiate with Medicare on certain drug prices.
ARTICLE TAGS
You must be logged in to access this content.